- Home
- GAME vs ICCM Comparison
GAME vs ICCM Comparison
Compare GAME & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GAME | ICCM |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.4M | 45.5M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | GAME | ICCM |
|---|---|---|
| Price | $0.45 | $0.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 1.2M | 353.1K |
| Earning Date | 11-13-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,810,388.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | $16.44 | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 188.95 | N/A |
| 52 Week Low | $0.42 | $0.59 |
| 52 Week High | $2.87 | $1.66 |
Technical Indicators
Market Signals| Indicator | GAME | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 39.41 | 43.85 |
| Support Level | $0.43 | $0.65 |
| Resistance Level | $0.46 | $0.68 |
| Average True Range (ATR) | 0.04 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 15.48 | 46.72 |
Price Performance
Historical ComparisonAbout GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.